Magnesiumsulfaat Teva (Magnesium Sulfate)

Magnesium sulfate, the active ingredient in Magnesiumsulfaat Teva, is an electrolyte presented as an injectable solution for intraarticular, intravenous and peri‑articular use. It is employed to replace magnesium deficits, prevent eclamptic seizures and treat certain cardiac arrhythmias. GNH USA supplies Magnesiumsulfaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is used across several clinical pathways related to electrolyte balance and cardiovascular stability. - Electrolyte replacement: restores normal magnesium concentrations in patients with deficiency or loss. - Eclampsia prevention and treatment: reduces the risk of seizures in pregnant women with pre‑eclampsia. - Cardiac arrhythmia management: stabilises cardiac membranes to treat torsades de pointes and other magnesium‑responsive arrhythmias. - Acute severe asthma adjunct: provides bronchodilation as a supportive therapy. - Peri‑articular analgesia: injected around joints to lessen postoperative pain.

Magnesium sulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Flushing or warmth sensation. - Nausea or vomiting. - Headache or dizziness. - Hypotension or mild drop in blood pressure. - Sweating or metallic taste.

Serious or Rare Side Effects: - Respiratory depression or apnea. - Severe hypotension or cardiovascular collapse. - Hypermagnesemia leading to cardiac arrest. - Anaphylactic or severe allergic reactions. - Arrhythmias such as heart block.

When using magnesium sulfate, clinicians should observe several safety measures. - Monitor serum magnesium: check levels before and during therapy. - Assess renal function: adjust dosing in patients with impaired clearance. - Use cautiously in cardiac disease: avoid rapid bolus in patients with conduction disorders. - Avoid concurrent high‑dose calcium channel blockers: risk of additive hypotension. - Adjust dose for elderly or frail patients: start with lower amounts. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Magnesium sulfate can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Neuromuscular blocking agents: potentiates muscle relaxation, risking prolonged paralysis. - Calcium channel blockers: additive hypotensive effect. - Other magnesium‑containing products: may cause hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop and thiazide diuretics: increase renal magnesium loss, may require dose adjustment. - ACE inhibitors or ARBs: enhanced potassium retention, monitor electrolytes. - Digoxin: altered cardiac conduction, observe for arrhythmias.